US Patent Issued to Alar Pharmaceuticals on Jan. 13 for "Long-acting injectable formulations and crystalline forms of buprenorphine derivatives" (Taiwanese Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,610, issued on Jan. 13, was assigned to Alar Pharmaceuticals Inc. (Taichung, Taiwan).

"Long-acting injectable formulations and crystalline forms of buprenorphine derivatives" was invented by Tong-Ho Lin (Taichung, Taiwan), Yung-Shun Wen (Taichung, Taiwan) and Jui-Wei Liang (Taichung, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to crystalline forms of 3-acyl-buprenorphine derivatives and sustained release injectable pharmaceutical compositions for treatment of opioid dependence, pain or depression, including an aqueous suspension of crystalline 3-acyl-buprenoprhine, or a pharmaceutically acceptable salt thereof, wher...